Home/Medicines/Ursodiol (Ursodeoxycholic Acid)
All medicines

Ursodiol (Ursodeoxycholic Acid)

Prescription
Hepatoprotectant / Bile acid (hydrophilic)
Last reviewed 19 Apr 2026 · PetCare.AI Editorial Team
Species
Dog, Cat
Brands
3 available
Formulations
2

Mechanism of action

Replaces hydrophobic toxic bile acids with hydrophilic ursodeoxycholic acid, protecting hepatocyte membranes; also has immunomodulatory, anti-inflammatory, and choleretic effects

At a glance

Class
Hepatoprotectant / Bile acid (hydrophilic)
Schedule
Prescription
Storage
Store below 25°C

Dosing

🐕

Dog

Chronic hepatitis / Cholestatic liver disease / Gallbladder mucocele (early)
Dose
10–15 mg/kg
Route
PO
Frequency
SID to BID (with food)
Max dose
600 mg
Duration: Long-term; months to years
🐈

Cat

Cholangitis / Hepatic lipidosis / Cholestatic disease
Dose
10–15 mg/kg
Route
PO
Frequency
SID (with food)
Max dose
150 mg
Duration: Long-term

Formulations

💊

Tablet — 2

Strength
150mg
Available in India
Strength
300mg
Available in India

Storage

Store below 25°C

Safety

Absolute contraindications — do not use

  • Complete biliary obstruction
    Bile cannot flow; drug ineffective

Use with caution

  • Concurrent aluminum-containing antacids
    Reduced absorption

Adverse effects

Common
Mild diarrhoea
Serious
Rare: hepatotoxicity at very high doses

Monitoring parameters

Hepatic enzymesBile acidsAbdominal ultrasound

Interactions

No documented interactions.

Brands

International

Actigall
Watson

India

Udiliv
Abbott India
Ursocol
Sun Pharma

FAQs

Frequently asked questions

What is Ursodiol (Ursodeoxycholic Acid)?
Ursodiol (Ursodeoxycholic Acid) is a hepatoprotectant / bile acid (hydrophilic) used in pets. Replaces hydrophobic toxic bile acids with hydrophilic ursodeoxycholic acid, protecting hepatocyte membranes; also has immunomodulatory, anti-inflammatory, and choleretic effects
What is Ursodiol (Ursodeoxycholic Acid) used for in pets?
Ursodiol (Ursodeoxycholic Acid) is used in veterinary medicine for: Chronic hepatitis / Cholestatic liver disease / Gallbladder mucocele (early); Cholangitis / Hepatic lipidosis / Cholestatic disease.
What is the Ursodiol (Ursodeoxycholic Acid) dose for dogs?
For dogs, Ursodiol (Ursodeoxycholic Acid) is typically dosed as follows — Chronic hepatitis / Cholestatic liver disease / Gallbladder mucocele (early): 10–15 mg/kg PO SID to BID (with food). Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
What is the Ursodiol (Ursodeoxycholic Acid) dose for cats?
For cats, Ursodiol (Ursodeoxycholic Acid) is typically dosed as follows — Cholangitis / Hepatic lipidosis / Cholestatic disease: 10–15 mg/kg PO SID (with food). Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
What are the side effects of Ursodiol (Ursodeoxycholic Acid)?
Common: Mild diarrhoea. Serious (call your vet immediately): Rare: hepatotoxicity at very high doses.
Does Ursodiol (Ursodeoxycholic Acid) need a prescription?
Yes. Ursodiol (Ursodeoxycholic Acid) is a prescription medication and should only be administered under veterinary supervision.
When should Ursodiol (Ursodeoxycholic Acid) not be used?
Do not use Ursodiol (Ursodeoxycholic Acid) if: Complete biliary obstruction.

References

References

Textbooks & handbooks

  • Plumb, D.C. Plumb's Veterinary Drug Handbook. 10th ed., Wiley-Blackwell, 2023.
  • Vail, D.M., Thamm, D.H., & Liptak, J.M. (eds.). Withrow & MacEwen's Small Animal Clinical Oncology. 6th ed., Saunders/Elsevier, 2020.
  • Riviere, J.E., & Papich, M.G. (eds.). Veterinary Pharmacology and Therapeutics. 10th ed., Wiley-Blackwell, 2018.
  • National Research Council. Nutrient Requirements of Dogs and Cats. National Academies Press, Washington DC, 2006.
  • The Merck Veterinary Manual. Merck & Co., Online edition. https://www.merckvetmanual.com/

Clinical guidelines & consensus

  • Fletcher, D.J., Boller, M., Brainard, B.M., et al. "RECOVER Evidence and Knowledge Gap Analysis on Veterinary CPR." Journal of Veterinary Emergency and Critical Care, 2012;22(S1):S102–S131.
  • American Animal Hospital Association. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. AAHA Press.

Journals & peer-reviewed studies

  • Hogan, D.F., Fox, P.R., Jacob, K., et al. "Secondary prevention of cardiogenic arterial thromboembolism in the cat: The FAT CAT study." Journal of Veterinary Cardiology, 2015;17(Suppl 1):S306–S317.
  • Boswood, A., Häggström, J., Gordon, S.G., et al. "Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study — A Randomized Clinical Trial." Journal of Veterinary Internal Medicine, 2016;30(6):1765–1779.
  • ASPCA Animal Poison Control Center. Toxicology and Poison Management Guidelines. American Society for the Prevention of Cruelty to Animals. https://www.aspca.org/pet-care/animal-poison-control

Regulatory & approvals

  • Central Drugs Standard Control Organisation (CDSCO), Government of India. Veterinary Drug Approval Registry, 1969–2026. Directorate General of Health Services. https://cdsco.gov.in/

Databases

  • Washington State University, College of Veterinary Medicine. Veterinary Clinical Pharmacology Laboratory (VCPL) — MDR1 Multidrug Sensitivity Database. https://vcpl.vetmed.wsu.edu/
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet. Find a vet near you →